Background of Kaiser’s Arbitration Controversy
The case of Wilfredo Engalla, a 51-year-old Filipino immigrant, underscores ongoing issues with Kaiser Permanente’s arbitration process. Engalla alleged that Kaiser doctors misdiagnosed him, leading to a late terminal lung cancer diagnosis. He passed away before his case could reach an arbitrator, exposing arbitration delays.
In 1997, the California Supreme Court criticized Kaiser’s arbitration system for being unfairly prolonged and disadvantageous to members. Despite reforms, recent scrutiny questions if the system remains biased against members.
Current Criticisms and Legislative Action
Critics maintain that Kaiser’s arbitration process still lacks fairness. Attorney Robert Garcia argues the system prioritizes Kaiser over malpractice claimants. Garcia, a Kaiser member, has proposed a bill for state oversight of health plan arbitrations by California’s attorney general.
Kaiser defends the system, claiming it offers fairness to all. Most firms delegate claims to large arbitration bodies, unlike Kaiser’s in-house system created in 1971. Both parties in arbitration may disqualify arbitrators without limit, but critics suggest Kaiser holds undue influence.
Claims of Bias and Repeat Player Effect
Allegations arise that Kaiser uses its system knowledge and history with arbitrators to gain favorable outcomes. Arlan Cohen, a physician and attorney, cites financial motivations for arbitrators to side with Kaiser for repeat selections in future cases.
Legal expert David Allen Larson highlights the “repeat player effect,” where habitual selection of arbitrators by Kaiser can lead to a perceived advantage over new complainants. These claims are supported by attorney Alan Kang, filing to void a past ruling against Evangelina Aquino’s family after reviewing patterns favoring Kaiser.
Kaiser’s Counterarguments and Arbitration Process
Kaiser denies manipulating arbitrator selection. They state the appointment process remains impartial; both parties receive information to veto uncomfortable choices. Arbitrators are not employed by Kaiser, ensuring independence according to law.
Kaiser’s arbitration system includes an Independent Administrator Office, funded by a trust and patient fees. This body manages selection from 195 panel members, allowing parties to object to arbitrators during the process.
Statistics and Settlements
In 2023, Kaiser closed 529 arbitration cases. Only 23 cases proceeded to hearings, with Kaiser prevailing in the majority. Cases are typically settled confidentially, with settlements raising patient safety issues.
Concerns persist about arbitration secrecy potentially hiding systemic safety flaws and poor medical practices. A case involving Francisco Delgadillo, who died waiting for care, exemplifies such confidentiality concerns, as his family’s arbitration claim settled undisclosed.
Stories of Missed Diagnoses
Patient experiences, like Janene Fowler’s missed Vitamin B12 deficiency diagnosis, raise questions about care under Kaiser’s watch. Despite evidence suggesting oversight, an arbitrator upheld Kaiser’s handling, intensifying debate on the arbitration system’s objectivity.
Fowler’s case illustrates the hardships patients face when navigating the arbitration system against a major health plan. Her condition resulted in long-term health impacts, intensifying her frustration with the system.
Continued Calls for Reform
Persistent patient complaints post-reform highlight dissatisfaction with the arbitrator impartiality. Stephen Martinez advocates for legislation to ensure equitable arbitration, citing personal experience in a bill introduced by Assemblyman Garcia.
The legislation seeks to enable the attorney general to ensure transparency and impartiality in health plan arbitrations, proposing additional state oversight resources. Kaiser views the bill as potentially redundant and burdensome.

Senator Roger Marshall Criticizes Dr. Anthony Fauci Over Vaccine Text Messages
Understanding Medicare Extra Help and Its Benefits
Trump’s Remarks on Childhood Vaccines Spark Debate
CDC Reports Drug-Resistant Fungus Candida Auris Cases Across 27 States
Medicaid Coverage and Its Impact on Pediatric Care
Challenges of Breaking Up MMR Vaccine